Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 143,091 | 54,123 | 65,061 | 4,570 | 106 |
| Operating Income | -143,091 | -54,123 | -65,061 | -4,570 | -106 |
| Other Income | 22,129 | 10,138 | 592 | 28 | 15 |
| Pre-tax Income | -120,962 | -43,985 | -64,470 | -4,543 | -91 |
| Income Tax | 282 | 94 | 36 | N/A | N/A |
| Net Income Continuous | -121,244 | -44,079 | -64,506 | -4,543 | -91 |
| Minority Interests | -2,309 | -8,072 | -14,533 | N/A | N/A |
| Net Income | $-118,936 | $-36,007 | $-49,973 | $-4,543 | $-91 |
| EPS Basic Total Ops | -1.89 | -0.73 | -1.70 | -0.31 | -0.04 |
| EPS Basic Continuous Ops | -1.93 | -0.90 | -2.20 | -1.58 | -0.03 |
| EPS Diluted Total Ops | -1.89 | -0.73 | -1.70 | -0.31 | -0.04 |
| EPS Diluted Continuous Ops | -1.93 | -0.90 | -2.20 | -1.58 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -1.89 | -0.73 | -1.70 | N/A | N/A |
| EBITDA(a) | $-141,706 | $-53,753 | $-64,897 | $-4,570 | $-106 |